FDA Notices of Judgment Collection, 1908-1966

856. Adulteration and misbranding of cascara compound tablets and Pentabisarsen ampuls. U. S. v. Max Gold and Irving Levine (Gold Leaf Pharmacal Co.). Plea of guilty. Fine, $500 on counts 2 and 4. Sentence suspended and defendants placed on probation for 1 year on counts 1 and 3.

Case Number:
856
Collection:
Drugs and Devices, 1940-1963
Evidence Numbers:
F. D. C. No. 6466. Sample Nos. 69921-E, 69925-E.
Date Issued:
May 1944
Seizure Dates:
May 9 to 12, 1941
Product Keywords:
cascara compound tablets and Pentabisarsen ampuls
Defendant Names:
Max Gold and Irving Levine, trading as the Gold Leaf Pharmacal Co., New Rochelle, N. Y.
Court Jurisdiction:
Southern District of New York
Seizure Location:
Connecticut
Shipped From:
New York
Shipped To:
Connecticut
Copyright:
The National Library of Medicine believes this item to be in the public domain (More information)